Issue: IeJSME 2024 18(2)

Authors: Sheema Gunasegaram, Seok Shin Tan, Sumaira Hussain

ABSTRACT

Academic stressors can hinder the wellbeing of students and impact their eating habits. In this study, we apply the socio-ecological model to academic stressors and explore the influence they have on eating behaviour among university students. This cross-sectional study was set in a private health sciences university in Malaysia among a sample of 183 pre-university students, which was obtained using systematic random sampling technique. The academic stressors of the participants were assessed using the Academic Stress Questionnaire while eating behaviour was determined using The Three Eating Factor Questionnaire Revised-18 Items. Significant association (p ≤ 0.05) was found between academic stressors and eating habits. The increase in academic stressors increased the unhealthy eating behaviours: Cognitive Restraint, Uncontrolled Eating, and Emotional Eating. The findings illustrate that academic stressors should be taken into consideration for future university health interventions to promote healthy eating behaviour.

Keywords: socio-ecological model, academic stressors, eating behavior, student

Citations: IeJSME 2024 Vol 18 (2): 06-15

DOI: https://doi.org/10.56026/imu.18.2.6

Authors: Siew Houy Chua, Wei Joe Lai, Yuan Fang Lim, Joshua Shadrach Daniel, Keshvien Inbashekaran, Suk Chyn Gun

ABSTRACT

Introduction: Coronavirus disease 2019 (COVID-19) has severely influenced all aspects of life since its emergence and one of the strategies to end this pandemic rests on the vaccination to achieve herd immunity. While vaccinations are usually a safe and effective tool, the abbreviated development process of the available COVID-19 vaccines has increased uncertainties about the safety among the general population especially among patients with rheumatic and musculoskeletal diseases (RMD).

Methods: A cross-sectional analysis was performed on rheumatic disease (RMD) patients from the rheumatology clinic at Hospital Tuanku Ja’afar Seremban (HTJS), investigating adverse events occurring within one month of receiving COVID-19 vaccines administered from 1st May 2021 to 30th September 2021.

Results: 549 RMD patients were recruited in this study. Pfizer/BioNTech was the predominant vaccine (n = 257, 64.3%), followed by Sinovac (n = 60, 47.2%), Oxford/AstraZeneca (n = 7, 1.3%) and Moderna (n = 1, 0.2%). 330 (60.1%) patients experienced at least one adverse event, none of which required hospitalisation. Common side effects included pain at the site of injection (n = 169, 30.8%), generalised muscle pain (n = 91, 16.4%), fever (n = 90, 16.4%), arthralgia (n = 55, 10.0%), and lethargy (n = 43, 7.7%). Female patients (OR = 0.88, CI 0.79-0.97, p = 0.012), Sinovac recipients (OR = 0.51, CI 0.34-0.76, p = 0.001) and age >50 years (OR = 0.62, CI 0.44-0.89, p = 0.009) had significantly lower risks of experiencing adverse events. Among patients with autoimmune rheumatic disease (AIRD), 28 (6.4%) experienced disease flare. Patients with spondyloarthropathy (SpA) and overlap syndrome were more likely to experience disease flare following COVID-19 vaccination compared to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients (OR = 2.87, CI 1.23 – 6.69, p = 0.014). The use of combination conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) was associated with a tendency toward increased risk of disease flare (OR = 2.34, CI: 0.97–5.64, p = 0.056). However, the use of glucocorticoids (OR = 2.02, CI 0.72–5.61, p = 0.17) and an active disease state (OR = 1.94, CI 0.75–5.02, p = 0.171) did not show a statistically significant impact on the frequency of disease flares.

Conclusions: The study affirms the overall safety of COVID-19 vaccines in rheumatic musculoskeletal disease patients, supporting efforts to address vaccine hesitancy in this population.

Keywords: Adverse events; COVID-19; Rheumatic and musculoskeletal disease; SARS-CoV-2; Vaccination

Citations: IeJSME 2024 Vol 18 (2): 16-24

DOI: https://doi.org/10.56026/imu.18.2.16

Authors: Haliza Abdul Mutalib, Bashirah Ishak, Mohd Norhafizun bin Mohd Saman, Ahmad Rohi Ghazali, Elly Liyana Zainodin.

ABSTRACT

Background
There are a few dry eye remedies available in the market. Currently, artificial tears and lubricants are still the most common management for dry eyes.

Objective
We proposed a new method in managing dry eyes.

Methods
A pre-soaked contact lens in virgin coconut oil (VCOCL) is being used as a vehicle to deliver virgin coconut oil (VCO) in dry eyes. VCOCL was prepared in sterilised conditions where daily soft hydrogel contact lenses were immersed in raw VCO. The efficacy of VCOCL in delivering the VCO to eyes was assessed by measuring the Tear Break-Up Time (TBUT) values, corneal staining of the anterior eye, Schirmer Test values and the measurement of residual VCO volume in tears at baseline and at 15 minutes after insertion on subjects with dry eyes. Pre- and post-data were used to analyse all the measurable variables.

Results
This study showed a significant difference in the TBUT, corneal staining, and residual VCO volume for both eyes (p<0.05). However, there were no changes in the Schirmer Test value (p>0.05). VCOCL was proven to improve tear quality in dry eye subjects and was able to maintain its presence in the eye even after 15 minutes.

Conclusion
This study suggests a new method for dry eye management.

Keywords: Contact Lens, VCO, Therapeutic, Dry Eye, Tearfilm

Citations: IeJSME 2024 Vol 18 (2): 25-34

DOI: https://doi.org/10.56026/imu.18.2.25